Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02180178 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registry

Study acronym: MICAT
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Sep 2023 to Sep 2028v11
  2. Re-verified, no change to tracked fieldsv10
  3. Study title revisedv9
  4. Primary and study completion dates: Sep 2020 to Sep 2023v8
  5. Study description expanded, about 66 wordsv7
Show 5 earlier versionsHide 5 earlier versions
  1. Primary and study completion dates: Sep 2019 to Sep 2020v6
  2. Primary completion date: Sep 2017 to Sep 2019
    • Study completion date: Sep 2018 to Sep 2019
    v5
  3. Primary completion date: Sep 2016 to Sep 2017
    • Study completion date: Sep 2017 to Sep 2018
    v4
  4. 2 versions Re-verified since Mar 31, 2015, no change to tracked fieldsv2-v3
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Primary goal of the registry is to collect prospective data on patients undergoing coronary angiography in Mainz. Following amendment of the procol, this study will also include patients who received an Aborb bioresorbable scaffold for the therapy of de novo stenoses.
Trial Details
NCT Number NCT02180178
Lead Sponsor Johannes Gutenberg University Mainz
Conditions
(from sponsor)		 Coronary Artery Disease, Microvascular Dysfunction
Related terms Coronary Artery Disease
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov